Carlson Capital’s Bausch Health BHC Stock Holding History

Carlson Capital’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-162,200	Closed	-$3M	–	250
2018 Q4	$3M	Buy	+162,200	New	+$3.86M	0.05%	236

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Carlson Capital's BHC Position: Q1 2019 in Review

Carlson Capital sold out of Bausch Health (BHC) in Q1 2019, closing a stake of 162,200 shares — an estimated $3M sold.

Carlson Capital first reported a position in BHC in Q4 2018 and held it in 1 quarter. The position peaked at $3M in Q4 2018. 349 funds tracked by Wall St. Rank hold BHC as of Q1 2019.

Carlson Capital reported no remaining Bausch Health position as of Q1 2019 after selling out during the quarter.
Carlson Capital sold 162,200 Bausch Health shares in Q1 2019, an estimated $3M.
Carlson Capital first reported a position in Bausch Health in Q4 2018 and held it in 1 quarter.
Carlson Capital's Bausch Health position peaked at $3M in Q4 2018.
349 funds tracked by Wall St. Rank held Bausch Health as of Q1 2019.

Based on Carlson Capital's 13F filing for Q1 2019, filed 14 May 2019.